March 18th at 3:00 p.m.
Antonio Uccelli, Università degli Studi di Genova
Novel Therapeutic Perspectives in Multiple Sclerosis
March 13h 2019 at 2:00 p.m.
Romina Belli & Daniele Peroni, MS Core Facility, Department CIBIO
Practicalities of MS-Based proteomics
March 8th 2019 at 2:00 p.m.
Ramanarayanan Krishnamurthy, Scripps Research Institute, San Diego, CA
Origins of Life - Chemistry to Biological Chemistry
March 4th 2019 at 3:30 p.m.
Samuele Notarbartolo, Cellular Immunology Group, Institute for Research in Biomedicine (IRB). Bellinzona - (Switzerland)
Characterization of two activation-dependent divergent fates in human TH17 cells
February 28th at 2:00 p.m.
Giulia Anselmi,The ONI, Linacre House, Oxford
ONI: the new dimension of super-resolution microscopy
February 27th at 2:00 p.m.
Thomas Seppi, Gerhard Tratter, Daniel Hekl. Hektros, Spinoff Università di Innsbruck
Advanced cell culture and the persistent self‐restraint of life sciences by doing‘flat biology’ – is this a paradox or not?
February 25th at 3:00 p.m.
Gabriella Viero, CNR Trento
Promises and Challenges in Sinal Muscular Atrophy Therapy
February 18th at 3:30 p.m.
Waldemar Vollmer, The Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University-Newcastle United Kingdom
Mechanisms and regulation of bacterial cell wall growth
February 4th at 3:00 p.m.
Andrea Calvo, Università degli Studi di Torino - CNR Trento
State of the Art of the Clinics in Amyyotrophic Lateral Sclerosis
January 29th at 3:00 p.m.
Richard White, Cancer Biology & Genetics Memorial Shoan Kettering Cancer Center Weill Cornell Medical College, New York
Zebrafish models of metastasis
January 25th at 2:00 p.m.
Filippo De Bene, Institut de la Vision, Department of Developmental Paris / France
Regulation of retinal progenitor cell differentiation by redox signaling and disease modeling in zebrafish with CRISPR/Cas9 based approaches
January 24th at 2:00 p.m.
Esther Baena, Prostate Oncobiology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester
Cell-of-origin of prostate cancer and clinical heterogeneity
January 18th at 2:30 p.m.
Tiziana Bonaldi, Department of Experimental Oncology, European Institute of Oncology, Milano
Methylation on and beyond histones, in health and disease mechanisms: a proteomic view